UBS Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-85,575
| Closed | -$342K | – | 7556 |
|
|
2019
Q4 | $342K | Sell |
85,575
-994,792
| -92% | -$3.98M | ﹤0.01% | 4206 |
|
|
2019
Q3 | $5.29M | Buy |
1,080,367
+434,698
| +67% | +$2.13M | ﹤0.01% | 1813 |
|
|
2019
Q2 | $3.93M | Buy |
645,669
+641,118
| +14,087% | +$3.9M | ﹤0.01% | 1989 |
|
|
2019
Q1 | $26K | Buy |
4,551
+985
| +28% | +$5.63K | ﹤0.01% | 5261 |
|
|
2018
Q4 | $48K | Buy |
3,566
+1,642
| +85% | +$22.1K | ﹤0.01% | 5229 |
|
|
2018
Q3 | $37K | Sell |
1,924
-345
| -15% | -$6.64K | ﹤0.01% | 5504 |
|
|
2018
Q2 | $58K | Sell |
2,269
-6,222
| -73% | -$159K | ﹤0.01% | 4980 |
|
|
2018
Q1 | $171K | Buy |
8,491
+5,526
| +186% | +$111K | ﹤0.01% | 4076 |
|
|
2017
Q4 | $60K | Buy |
2,965
+1,927
| +186% | +$39K | ﹤0.01% | 4764 |
|
|
2017
Q3 | $22K | Sell |
1,038
-100
| -9% | -$2.12K | ﹤0.01% | 5491 |
|
|
2017
Q2 | $17K | Hold |
1,138
| – | – | ﹤0.01% | 5493 |
|
|
2017
Q1 | $18K | Sell |
1,138
-1,030
| -48% | -$16.3K | ﹤0.01% | 5318 |
|
|
2016
Q4 | $27K | Sell |
2,168
-5,502
| -72% | -$68.5K | ﹤0.01% | 5390 |
|
|
2016
Q3 | $215K | Sell |
7,670
-1,638
| -18% | -$45.9K | ﹤0.01% | 3686 |
|
|
2016
Q2 | $325K | Buy |
9,308
+326
| +4% | +$11.4K | ﹤0.01% | 3445 |
|
|
2016
Q1 | $246K | Sell |
8,982
-20,141
| -69% | -$552K | ﹤0.01% | 3645 |
|
|
2015
Q4 | $996K | Buy |
29,123
+1,688
| +6% | +$57.7K | ﹤0.01% | 2693 |
|
|
2015
Q3 | $788K | Sell |
27,435
-14,204
| -34% | -$408K | ﹤0.01% | 2816 |
|
|
2015
Q2 | $1.86M | Buy |
41,639
+6,950
| +20% | +$311K | ﹤0.01% | 2363 |
|
|
2015
Q1 | $1.2M | Buy |
34,689
+31,449
| +971% | +$1.09M | ﹤0.01% | 2675 |
|
|
2014
Q4 | $88K | Buy |
+3,240
| New | +$88K | ﹤0.01% | 4314 |
|